𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-[123I]iodobenzyl)-1,3-propanediamine

✍ Scribed by S.M. Moerlein; G.S. Lannoye; M.J. Welch


Book ID
103922475
Publisher
Elsevier Science
Year
1990
Weight
444 KB
Volume
41
Category
Article
ISSN
0883-2889

No coin nor oath required. For personal study only.

✦ Synopsis


The multi-millicurie production of the SPECT radiopharmaceutical N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-[123I] iodobenzyl)-1,3-propanediamine [( 123I]HIPDM) in high specific activity is described. Using no-carrier-added electrophilic iododeprotonation reactions and HPLC purification, [123I]HIPDM can be isolated in 70-76% radiochemical yield and specific activity greater than 2000 Ci/mmol within an overal preparation time of 75 min. This methodology is readily adapted to the clinical setting, and eliminates the need for co-injection of macroscopic HIPDM in SPECT imaging procedures.


📜 SIMILAR VOLUMES


Radiosynthesis of [123I]N-(3-iodoprop-(2
✍ Meixiang Yu; Anu J. Airaksinen; Antony D. Gee; Simo Lötjönen; Jyrki T. Kuikka; J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB

## Abstract The radiosynthesis of a novel tropane derivative [^123^I]KUC‐25019, [[^123^I];__N__‐(3‐iodoprop‐(2__E__)‐enyl)‐2α‐(imino‐methyl)‐3β‐(3′,4′‐dichlorophenyl)nortropane], a potential inhibitor of the dopamine transporter is reported. The synthetic routes include the preparation of standard